Income Statement (OCUPHIRE/PHARMA)

Technical Analysis Historical Data Financials News & Analysis

OCUPHIRE/PHARMA NEWS

HC Wainwright Reaffirms “Purchase” Ranking for Opus Genetics (NASDAQ:IRD) By MarketBeat - 3 days ago

Opus Genetics (NASDAQ:IRD – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga r… [+2899 chars]...

Read more
Opus Genetics (NASDAQ:IRD) Downgraded to “Promote” Ranking by way of Wall Side road Zen By MarketBeat - 3 days ago

Wall Street Zen downgraded shares of Opus Genetics (NASDAQ:IRD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. Other analysts also recently iss… [+2867 chars]...

Read more
Retinitis Pigmentosa Analysis File 2025: $25+ Bn Marketplace Alternatives and Ideas to 2034 - Gene Remedy Poised as Quickest Rising Medicine Phase, Strategic Collaborations Power Developments By Research - 6 days ago

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and… [+11183 chars]...

Read more
Complete Age-related Macular Degeneration Marketplace Evaluation: Traits and Advancements Throughout All Styles By DelveInsight - 2 weeks ago

New York, USA, June 16, 2025 (GLOBE NEWSWIRE) -- Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsights analysis, the mar… [+9475 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		212.03 2.24
1.07%
CVX 		147.98 2.41
1.66%
CAT 		398.43 7.51
1.92%
INTC 		21.88 -0.97
-4.25%
MSFT 		491.09 -0.96
-0.2%
DIS 		122.98 -0.51
-0.41%
DOW 		28.73 0.9
3.23%
CSCO 		68.59 -0.51
-0.74%
GS 		715.89 9.43
1.33%